- Lead projects on validating new drug targets for oncology and immuno-oncology with different therapeutic modalities (small molecule, mono-/bi-specific antibody, recombinant protein, mRNA/LNP).- Designed and executed target validation and mechanism-of-action (MoA) studies.- Developed cell-based assays, planned and oversaw in vivo studies.

Studied the mechanisms underlying prostate cancer development and progression

- Developed a 3D breast tumor model in vitro for high throughput small molecule screens for compounds that suppress tumor formation; - Won highly competitive Postdoctoral Fellowships from Alberta Cancer Foundation, Canadian Institutes of Health Research, and CIHR Training Program in Genetics, Child Development and Health.

- Studied functions and properties of lipid kinases involved in the phosphoinositide cycle: identified differences in the roles in lipid metabolism of diacylglycerol kinase isoforms, determined substrate and inhibitor/activator specificity of diacylglycerol kinases and PI kinases- Graduated as Valedictorian, Class of 2012, Faculty of Health Sciences and Faculty of Science- Published 12 papers in peer-reviewed journals, including 7 first-author papers, and presented at 6 conferences (oral and poster presentations)- Featured in the Student Spotlight section of the Biophysical Society's newsletter (July2012 issue): http://www.biophysics.org/Publications/Newsletter/PastIssues/July2012/StudentSpotlight/tabid/4025/Default.aspx

Broadened knowledge in protein chemistry by working as a summer research student at WeizmannInstitute of Science, Rehovot, Israel